This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

5 Things You Should Know Before the Stock Market Opens

NEW YORK (TheStreet) -- U.S. stock futures were pointing lower Monday after weak jobs growth in the U.S. had investors fretting growth in the world's-largest economy was losing momentum.

European stocks were trading lower, while Asian stocks ended Monday on the downside.

Japan's Nikkei 225 index fell 1.4% o 8,896.88 while China's Shanghai Composite declined 2.4% to 2,170.81. Inflation figures for China released Monday showed the consumer price index at its lowest since January 2010, giving Beijing more room to continue adding stimulus.

U.S. stocks on Friday fell after a Labor Department report showed the U.S. economy produced fewer than 100,000 jobs for the third month in a row.

The Dow Jones Industrial Average declined 124.20 points, or 0.96%, to 12,772, and closed down 0.84% for the week. The S&P 500 slipped 12.90 points, or 0.94%, to 1,355; it closed down 0.55% for the week.

The Nasdaq slid 38.79 points, or 1.3%, to 2,937, and was flat for the week.


The economic calendar in the U.S. on Monday is light, with only May U.S. consumer credit numbers to be released at 3 p.m. EDT.


Details are emerging on how eurozone officials will set up a banking supervisor for the 17-nation currency bloc, according to a report.

Discussions are centering on the idea of an agency under the European Central Bank that will be the sole overseer of the 25 or so biggest banks in the eurozone, according to a report from The Wall Street Journal.

Smaller banks in the currency bloc would continue to be supervised by their national financial-market regulators, the report said. But the national regulators would be under the control of the eurozone banking supervisor.


Alcoa (AA) kicks off second-quarter earnings season after Monday's closing bell and analysts expect the aluminum giant to report profit of 5 cents a share on revenue of $5.83 billion.


Celgene (CELG) isn't buying Human Genome Sciences (HGSI), according to a source in contact with Celgene management, reported TheStreet's Adam Feuerstein.

Late Friday, Reuters, citing its own unnamed source, reported that Celgene was one of two possible bidders for Human Genome Sciences, which is trying to fight off a hostile, $13-a-share offer from GlaxoSmithKline (GSK).

Stock quotes in this article: AA, CELG, HGSI 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,510.81 +9.16 0.06%
S&P 500 1,879.32 +3.93 0.21%
NASDAQ 4,149.7690 +22.8020 0.55%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs